PRCT Q3 2023 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$35M+72.5% YoY

Gross Profit

$19M53.8% margin

Operating Income

-$26M-73.0% margin

Net Income

-$25M-70.1% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

+6.0%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$25M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$421M

Total Liabilities

$122M

Stockholders' Equity

$299M

Cash & Equivalents

$288M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$20M	+72.5%
Gross Profit	$19M	$10M	+84.5%
Operating Income	-$26M	-$22M	-15.9%
Net Income	-$25M	-$23M	-8.9%

Geographic Segments

UNITED STATES

$32M92%

Outside the United States

$3M8%